Capital World Investors 13D and 13G filings for Regeneron Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 6:19 pm Sale |
2024-02-07 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
Capital World Investors | 5,194,729 4.800% |
-1,121,090 (-17.75%) |
Filing |
| 2023-02-13 2:49 pm Purchase |
2023-02-14 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
Capital World Investors | 6,315,819 5.900% |
923,949 (+17.14%) |
Filing |
| 2022-02-11 2:48 pm Sale |
2022-02-14 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
Capital World Investors | 5,391,870 5.100% |
-1,625,252 (-23.16%) |
Filing |
| 2021-02-16 1:00 pm Sale |
2021-02-16 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
Capital World Investors | 7,017,122 6.700% |
-1,334,829 (-15.98%) |
Filing |